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ABSTRACT
Background: Mammography screening may cause psychosocial harm for women experiencing
a false-positive screening result. Previous studies suggest long-term consequences. The aim of
the present study was to assess psychosocial consequences of false-positive findings on screen-
ing mammography within a six month follow-up.
Methods: A prospective matched cohort survey study using the questionnaire ‘Consequences of
Screening for Breast Cancer’ (COS-BC), which was translated from Danish to Norwegian.
Psychometric analyses investigated the measurement properties of the Norwegian version. Two
screening clinics in Norway distributed the survey to 299 women with an abnormal mammo-
gram and 541 women with a normal screen. Women received the questionnaire when receiving
the screening result, and one and six months after screening.
Results: At six months, statistically significant differences appeared in two scales: existential val-
ues and breast examination. At six-month follow-up, women with false-positive results showed
no statistically significant differences from women diagnosed with breast cancer in three out-
comes: sense of dejection, anxiety, and keeping my mind off things.
Conclusion: Our results indicate that the psychosocial consequences from having false-positive
screening mammography results diminish after six months. The results support previous
research describing breast-specific outcomes. However, our results indicate that Norwegian
women are less frightened than other Scandinavian mammography screening participants.
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Introduction
In cancer screening, some individuals who do not have
cancer are subject to follow-up examinations due to an
abnormal screening result. Having a false-positive
screening mammography (hereafter referred to as false
positives) may lead to adverse psychosocial consequen-
ces. Several reviews have concluded that short-term
adverse psychological consequences of mammography
screening are significantly higher for women with false
positives than for women who receive normal screen-
ing results in the first three months after mammog-
raphy [1,2]. Long-term consequences are contested.
Several studies have found no increased long-term lev-
els of generalized anxiety among women who experi-
ence false positives [3–10]. Other studies report that
anxiety was greater among false positives compared to
women with normal results in a 12 months period
[7,11], or even up to 24 months [12]. One review
concluded that there were no long-term symptoms of
generalized depression among women with false posi-
tives [13]. A Norwegian study among women who
experienced a recall found transiently increased anxiety
and a slight increase in depression. Four weeks after
screening the level of anxiety was the same as that of
the general female Norwegian population, whereas
depression levels were lower [14]. A more recent
Norwegian study found no effect on anxiety but
increased depression as long as six months after false
positive diagnoses [15]. In a Danish longitudinal study,
women with false positives reported changes in exist-
ential values and inner calmness as great as those
reported by women diagnosed with breast cancer at
six-month follow-up [16]. Three years after being
declared cancer free, women with false positives con-
sistently reported greater negative psychosocial conse-
quences than women who had normal findings [16].
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Variance in psychosocial consequences from screen-
ing in different studies could be caused by what is
measured, and how [17]. There has been a need for
studies using adequate tools for measuring psycho-
social consequences from having a false-positive result
from screening, as such tools must cover anxiety, fear,
mood, behaviour, sleep, sexuality and social function-
ing [18]. While studies using generic measures
designed to measure general anxiety and depression
at clinically relevant levels do not find significant
negative psychological impact from having false posi-
tives, those using condition-specific instruments do
[2]. In a meta-analysis, having false positives had little
effect on generalized outcomes, but had significant
effects on breast-cancer specific outcomes, including
distress about breast cancer, somatization or symp-
toms in the breast, fear of getting breast cancer, anx-
iety and worry about breast cancer, perceived benefits
of mammography, and frequency of breast self-exams
[1]. To meet the need for a condition-specific instru-
ment for mammography screening, the questionnaire
‘Consequences of screening’ [4] was developed and
validated into ‘Consequences of screening – breast
cancer (COS-BC)’ to fit studies on breast cancer [19].
Previous international research has shown that having
a false-positive result after mammography screening
can have short-term, breast specific psychosocial con-
sequences. In this study we present results from the
Norwegian version of the COS-BC to examine the psy-
chosocial consequences of a false-positive result in a
Norwegian population.
Aim of study
The overall aim of this study was to assess psycho-
social consequences of false-positive findings on
screening mammography within a six-month follow-
up. To do so adequately, the Danish version of COS-
BC was translated and adapted into Norwegian, and
the domains were tested for reliability and unidimen-
sionality using Rasch modeling.
Methods and material
Study context and population
The Norwegian Breast Cancer Screening Programme
invites all women aged 50–69 years to biennial mam-
mography. Between 1996 and 2010, more than two
million screening examinations were performed in the
programme [20]. Participation is covered by the
national health insurance, with the exception of an
individual payment of approximately 200 Norwegian
kroner. Within the screening programme, the cumula-
tive risk of false positives has been found to be 23%,
with the rate for false positive screening results vary-
ing between 1.8% and 4.1% across screening
units [20].
The questionnaire and translation to Norwegian
COS-BC consists of two parts. Part-I encompasses 29
items: two single items (‘Felt less attractive’ and ‘Busy
to take my mind off things’) and six scales measuring
anxiety (6 items), sense of dejection (6 items), negative
impact on behaviour (7 items), sleep (4 items), degree
of breast self-examination (2 items), and sexuality (2
items) [21]. All items in Part-I have four response cate-
gories: ‘not at all’, ‘a bit’, ‘quite a bit’ and ‘a lot’. The
higher the score of the outcome, the more negative
psychosocial consequences the person has experi-
enced [21]. Part-II consists of 13 items for those who
had a screening negative or a false-positive result,
while two items concerning belief in having breast
cancer were left out for those diagnosed with breast
cancer. Part-II encompasses four scales: existential val-
ues (6 items), relationships within social network (3
items), being less or more relaxed/calm (2 items), and
being less or more anxious about breast cancer/belief
in having or not-having breast cancer (2 items) [22].
All items in these scales have five response categories:
‘Much less’, ‘Less’, ‘The same as before’, ‘More’, and
‘Much more’. Changes following existential crisis can
be interpreted by the individual as positive or nega-
tive, or a combination of both. Therefore, Part-II
requires a ‘laterally reversed’ scoring system: A
response to ’The same as before’ becomes a value of
‘No change’, a response to ‘Less’ or ‘More’ becomes a
value of ‘Minor change’, and a response to ‘Much less’
or ‘Much more’ becomes a value of ‘Major change’
[22,23]. The four sum-scores of Part-II reflect the
degree of changes in the four long-term psychosocial
outcomes respectively. A high score in part-II denotes
that the individual is highly psychosocially affected,
irrespective of this being a positive or negative experi-
ence [22,23].
The Danish COS-BC was the original version of the
questionnaire [22]. It has demonstrated adequate psy-
chometric measurement properties: high content val-
idity, evidence of uni-dimensionality, and limited DIF
founding in the Rasch analysis. It was translated and
adapted into Norwegian using the dual panel method
[24]. The original version was translated into
Norwegian in a consensus meeting among three bilin-
gual people moderated by JB. If an item could be
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translated into Norwegian in two or more ways, they
were allowed to suggest these alternatives to the next
panel. Second, this Norwegian draft version of the
COS-BC was tested in a lay panel. Criteria for the five
lay panel members were to have Norwegian as their
first language, no particular knowledge of Danish, no
health-related education, no higher education, and
being eligible for the mammography programme. Any
changes suggested by the lay panel were incorpo-
rated. If the bilingual panel had suggested two or
more translations, the lay panel decided which was
closest to Norwegian lay language. Finally, this second
draft version of the Norwegian COS-BC was tested in
single interviews with ten women who had partici-
pated in the mammography programme. Three inter-
viewees had previously experienced false positives.
While completing the questionnaire, they discussed it
with a researcher, using the ‘think-aloud’ method [25].
All found the questionnaire easy to complete. The
heading ‘to women who have been invited to
mammography’ was changed to ‘to women who have
been to mammography’. Three women found it hard
to answer the question ‘time has felt long’, which was
changed to ‘time has passed slowly’. No other changes
were made to the questionnaire. The Norwegian ver-
sion of COS-BC do not show variance in the Rasch
analyses compared to the Danish version.
Study design and survey administration
The Regional Committee for Medical and Health
Research Ethics approved the study. The survey was
administered through two regional hospitals in North
and Central Norway, which provides all mammography
screening recall examinations in their region. All
women who had an abnormal screening mammog-
raphy during the study period April through
December 2010 received the questionnaire. For each
recalled woman included, two women with negative
findings who had been screened at the same date
and unit were additionally included in the study. Due
to summer closing, 29 screen positives were not
matched with screen negative women.
The two hospitals had different handling time for
interpreting mammographic images, which led to two
sampling procedures. At one hospital, women received
a letter including their screening result one week after
the mammography examination. Screen positives
received their first questionnaire together with their
recall letter. Screen negatives received their first ques-
tionnaire two weeks after the letter with screening
results had been sent. At the other hospital, women
had their screening result within four weeks after the
examination. Screen positive women received their
first questionnaire together with their recall letter,
whereas the control group received their first ques-
tionnaire 4–5 weeks after screening.
All questionnaires were sent from the hospital to
the women’s home addresses and returned in a pre-
paid envelope. Returning the first questionnaire was
seen as giving informed consent to participate in the
study. Women who returned their first questionnaire
received the COS-BC at two additional follow-up time
points: One and six months after receiving their
screening results. Only women who returned the
second questionnaire received the third. Through an
inadvertence, some women received questionnaire 3
without having answered questionnaire 2 (see Figure
1). A secretary at each hospital assigned numbers to
each woman and kept track of their diagnostic status.
Researchers did not know the identity of the women
and the hospital staff could not see the responses.
Three sociodemographic variables were registered:
the region where the women lived signified by the
hospital the women had been examined at; the
degree of urbanization in which the women lived sig-
nified by their postal code; and their age.
Statistical methods
Psychometric analysis
The psychometric properties of the 10 COS-BC scales
were tested for homogeneity and differential item func-
tioning (DIF) relative to participant age by using likeli-
hood ratio tests on appropriately conditioned Rasch
models at the 1 month follow-up time point [1].
Reliability of the scales was examined using Cronbach’s
alpha [26]. The software programme DIGRAM was used
for these psychometric analyses [27].
Longitudinal analysis
A COS-BC dimension was set to missing for a certain
time point in the follow-up if one or more items com-
prising the dimension were missing at the correspond-
ing time point. Also the response category ‘not
applicable’ in the sexuality dimension counted as
missing in this respect.
Multivariable linear regression was used to analyse
the differences in the developments of each of the
COS-BC dimensions over the three follow-up time
points between the screening groups; the analyses
were adjusted for the baseline factors. To adjust for a
possible different response pattern in the three
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groups, the non-missing dimensions at each time
point were weighted by the inverse of an estimate of
the probability of this score being observed. These
probabilities were estimated in logistic regression
models for the domain being missing, with the base-
line covariates, the screening groups, and the
observed scores of the corresponding domain at previ-
ous time points as covariates. Generalized estimating
equations were used to adequately adjust the covari-
ance for repeated measurement and weighting.
SAS 9.4 was used for the longitudinal analyses with
a statistical significance level of p< 0.01. Three com-
parisons were done in the analysis: between women
with negative and false-positive findings, between
women with negative screening results and women
with breast cancer, and between women with false
positives and women with breast cancer. Each com-
parison was done at the three assessments points.
Results
COS-BC was sent to 299 women who had an abnor-
mal screening mammography, of which 127 women
participated in the first round (99 with false positives
and 28 women with breast cancer). At one-month fol-
low-up 61 women with false positives and 25 women
with breast cancer completed the COS-BC, and 52 and
22 women participated at six months, respectively. As
controls, 541 women with normal screening results
received the first questionnaire, of which 261 were
returned, 188 at one month, and 160 after six months.
We found no statistically significant differences
between the three screening groups in relation to
age, urban/rural residence, or to which hospital they
belonged (Table 1).
The 10 Norwegian COS-BC scales exhibited overall
fit to the partial credit Rasch model for polytomous
items (Table 2). No DIF was revealed and Cronbach’s
Alpha was 0.652–0.926 (Table 2).
Normal screening results compared to breast
cancer diagnosis
The differences in psychosocial consequences between
women who had a normal screening result and
women diagnosed with breast cancer persisted
throughout one and six months (Figure 2, Table 3).
False positives compared to normal
screening results
There were differences between women with a normal
screen and false positives at baseline with respect to
all scales, except Negative impact on sexuality. At six
months, the only significant differences were for the
Figure 1. Flow-chart.
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two scales: Breast examination and Existential values.
See Table 3.
False positives compared to breast
cancer diagnosis
At baseline, there were no differences between
women who had false positives and diagnosed with
breast cancer. From baseline to one month, differen-
ces increased on all scales and items. Between one
and six months, differences increased between the
two groups, except for two scales and one single
item: Sense of dejection, Anxiety, and Keeping my mind
off things, which all showed larger differences at one
month than at six months.
Discussion
The present study included a small population with a
low response rate: 43% for screen positives and 48%
for women with a normal screening result, which is a
limitation. An indication of selection bias is the same
age in all the sub-groups: it was expected that women
diagnosed with breast cancer were older. We cannot
adjust for this possible selection bias as we had no
socio-demographic data on non-responders. Dropout
rates indicate that the study was most relevant for
women diagnosed with breast cancer. A potential lack
of relevance for those with a normal screening result
was supported by comments from women in the val-
idation test panel who had not been recalled after
mammography screening. In our study women with
false positives had the lowest participation rate after
six months. This is different from studies from the
other Scandinavian countries [16,28]. After six months,
the Danish study obtained a participation rate of
73.9%, the Swedish study 71%, while the present
study only obtained a participation rate of 53%
among women with false positives. Inviting women
with a positive finding from mammography screening
to answer questions about psychosocial consequences
may have ethical implications. Some women might
find such questions disturbing, reinforcing negative
feelings. However, since mammography screening is
targeting non-symptomatic women, the importance of
exploring its consequences is vital in order to attend
to women who are invited to screening.
Other limitations to the study are that there are
few background variables and no registration of socio-
economic status of study participants, and that
29 women with a positive screening result could not
be matched with a comparative selection due to
Table 2. Conditional likelihood ratio (CLR) fit statistics and Cronbach’s alpha for the 10 domains of the Norwegian
Consequences of Screening – Breast Cancer (COS-BC) questionnaire.
Scales (no. of items) CLR Degrees of freedom p Cronbach’s alpha
1 Anxiety [6] 12.8 15 0.617 0.921
2 Behaviour [7] 11.0 17 0.858 0.878
3 Dejection [6] 2.4 17 0.990 0.918
4 Negative impact on sleep [4] 11.3 11 0.418 0.926
5 Breast self-examination [2] 0.8 5 0.977 0.789
6 Sexuality [2] 10.3 5 0.068 0.813
7 Less or more anxious about breast cancer [2] 1.1 3 0.782 0.652
8 Calm/relaxed [2] 1.3 3 0.731 0.700
9 Social network [3] 2.0 5 0.852 0.672
10 Existential values [6] 23.3 11 0.016 0.925
After adjustment for multiple testing by using the methods of Benjamini–Hochberg, the level of statistical significance was assessed at a level of 0.05.
Table 1. Baseline characteristics of the screened population.
Screening result
Total Normal False positive Breast cancer
(n¼ 388) (n¼ 261) (n¼ 99) (n¼ 28)
n/n/n n (%) n (%) n (%) n (%) p-Value
Age
51–55 261/99/28 125 (32.2) 82 (31.4) 39 (39.4) 4 (14.3) 0.3420
56–60 92 (23.7) 62 (23.8) 22 (22.2) 8 (28.6)
61–65 103 (26.6) 71 (27.2) 22 (22.2) 10 (35.7)
66–70 68 (17.5) 46 (17.6) 16 (16.2) 6 (21.4)
Residence
Rural 261/99/28 156 (40.2) 98 (37.6) 47 (47.5) 11 (39.3) 0.2285
Urban 232 (59.8) 163 (62.5) 52 (52.5) 17 (60.7)
Hospital
Bodø 261/99/28 224 (57.7) 155 (59.4) 52 (52.5) 17 (60.7) 0.4736
Trondheim 164 (42.3) 106 (40.6) 47 (47.5) 11 (39.3)
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Figure 2. The mean score of each of the 8 psychosocial outcomes, part I of the COS-BC for the 3 screening groups at 3 time
points: 0, 1, and 6 months.
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summer closing at one hospital. The latter implies a
slight drop in power, but does not bias the results. All
analyses were performed using the method of general-
ized estimating equations so as to adjust for the
excess correlation of observations within matched
groups. Data was collected in 2010. Since then, infor-
mation leaflets from the Norwegian Breast Cancer
Screening Programme have been redesigned. This may
influence how women experience their screening par-
ticipation. However, the organization of the mammog-
raphy screening programme and the recall process is
the same in 2018 as in 2010, which suggest that our
results remain valid. Women with positive screening
results got the questionnaire together with the recall
letter and were encouraged in the information letter
to complete the questionnaire before attending their
recall examination. It is however impossible to know if
some waited until after the examination. Women who
had normal screening results received the COS-BC
questionnaire two to five weeks after receiving their
result from the examination. Variance in timing of
completing the questionnaire could have influenced
their answers, but previous research indicate that
receiving a ‘no-findings’ message is unlikely to cause
psychological consequences [29].
Previous research indicates that having false posi-
tives may lead to negative psychosocial consequences.
A meta-analysis found that although there were minor
psychosocial consequences identified via generalized
measures, false positives had an influence on breast-
specific items [1]. In the present study, women who
experienced false positives differed from women with
a normal screen on changes in two scales at 6-month
follow-up: Existential values and Breast examination
with a difference in score of 1.3 and 0.58 respectively.
For example, a statistically significant mean increase of
a score of 1 in the scale of Existential values corre-
sponds to a shift in responses from ‘no changes’ to
‘minor changes’ or from ‘minor changes’ to ‘major
changes’ in one item in this scale for every women
having false positives. We think that such a change is
of social and clinical significance. One explanation for
this is that these women have been subject to a raised
awareness of their personal breast cancer risk [30,31].
Another explanation is that women in an opt-out
mammography screening programme have not con-
sidered their risk of a recall when entering the pro-
gramme [13]. Women may participate in screening to
confirm that they are free of breast cancer [30,32].
After six months, women with false positives did not
Figure 2. Continued.
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differ from those with a normal screening result on
the item ‘worried about breast cancer’. One explan-
ation is the selection bias plus the low response rates.
This is supported by Swedish and Danish studies,
which found that those most positive to screening
have higher participation rates than those who are
more worried [16,28].
We found no statistically significant differences
between women who had false positives and those
who were diagnosed with breast cancer, regarding
breast examination after six months. This indicates
that false positives may influence awareness about
breast cancer in healthy women. However, in the scale
Breast examination there were no statistically signifi-
cant differences between women with normal screen-
ing results and women with breast cancer. This could
be due to a type 2-error because of the small number
of participants with breast cancer, which is a limitation
for all our findings comparing women with breast can-
cer to the two other groups.
Existential values remained significantly different
between women with false positives and women with
normal screening results at 6-month follow-up. This
shows the ability of COS-BC to detect subtle changes
from having false positives. Qualitative studies find
that women’s experiences from false positives are var-
ied and multifaceted [30–32]. These changes and
experiences may be difficult to measure quantitatively.
We cannot know if the change in existential values
were experienced positively or negatively by the
women. However, in our interpretation, changes
among non-symptomatic individuals due to participa-
tion is a negative feature of screening.
The Danish and Swedish studies with COS-BC found
significant differences between women with false posi-
tives and normal screening results in some of the
scales in part-I of COS-BC [16,28]. Our study did not
find the same level of negative psychosocial conse-
quences. Other Norwegian studies indicate similar
trends. One such study indicated that the anxiety level
was the same and depression was lower for those
with a false-positive screen compared to the general
female Norwegian population, four weeks after screen-
ing [14]. Another study found no effect on anxiety,
but increased depression six months after having false
positives [15]. Bias in recruitment, challenges with the
questionnaire, or the lack of possibility to adjust for
potential confounding such as socio-demographics
could explain why Norwegian women seem less fright-
ened by having false positives than other
Scandinavian women. Other explanations might be
how information is provided before screening, or trust
in health services. Because psychosocial effects have
the potential to affect many of the women participat-
ing in mammography screening, it is important to
make these questions the subject of further research.
Conclusion
This study found psychosocial consequences for
women who have false positives at one month, but
only in two of twelve psychosocial outcomes at
six months. Our study adds to previous research on
indicating that false positives may lead to increased
worries on breast cancer-specific items as long as
six months after participating in mammog-
raphy screening.
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